ELUT Elutia signs definitive agreement to sell simpliderm® in transaction valued at up to $11M, strengthening balance sheet ahead of nxt-41x
ELUT Elutia signs definitive agreement to sell simpliderm® in transaction valued at up to $11M, strengthening balance sheet ahead of nxt-41x launch
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.